New shot in the eye aims to halt leading cause of blindness
Disease control
Not yet recruiting
This is an early-stage study testing a new medication called GB10, which is injected into the eye. It aims to see if GB10 is safe and can help control 'wet' age-related macular degeneration (AMD), a major cause of vision loss. The study will test different doses in up to 48 peopl…
Phase: PHASE1 • Sponsor: Shenzhen Kexing Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC